新聞集錦
NEW

禮來IL-23抑制劑擴適應症 獲批治中重度克隆氏症；GE HealthCare攜手UCSF 創癌症、神經退化性疾病影像研究中心
生技醫藥
NEW

Vetter開發新一代V-OVS®注射器封蓋系統 估2027年推出  

生技醫藥
NEW

清大攜手國衛院 開發腸道慢性發炎新機轉新藥

GBI International
GBIHighlights

Dr. Tse Wen Chang, Taiwan's antibody pioneer, invented Xolair which was the first anti-IgE antibody

2023-12-31/GlobalBio & Investment
Excitingnewsintheantibodyworld!Dr.TseWenChang,Taiwan'santibodypioneer,inventedXolair(#omalizumab)whichwasthefirstanti-IgEantibody.FDAisexpectedtoreviewitssBLAsubmittedbyRocheforfoodallergybyQ12024...
GBI International
GBIHighlights

Learn from Dr. Andrea Carfi, Moderna’s Chief Scientific Officer, about their mRNA library...

2023-12-31/GlobalBio & Investment
Preparetoprevent#1Prepareforthenextpandemic?Moderna’svaccinestrategyisunderway!Howdotheyusepastexperiencestoswiftlydevelopvaccinesagainstunknownthreats?LearnfromDr. AndreaCarfi, Moderna’sC...
GBI International
GBIHighlights

Jellox partnered with China Medical University Hospital to bring digital pathology tech to Malaysia

2023-12-31/GlobalBio & Investment
Kudosto JelloXBiotechInc. foradvancinghealthcaredigitizationinMalaysia!!JelloxpartneredwithChinaMedicalUniversityHospital(#CMUH)tobringdigitalpathologytechtoMalaysiaunderTaiwan's"OneCountry,O...
GBI International
GBIHighlights

BRIM Biotechnology, Inc. ’s dry eye drug missed the primary goal in its late-stage trial

2023-12-31/GlobalBio & Investment
Everysetbackisasteppingstone!Thejourneyofdrugdevelopmentisascientificexploration.Eachhurdleisn’ttheendgame. BRIMBiotechnology,Inc. ’sdryeyedrugmissedtheprimarygoalinitslate-stagetrial.What...
GBI International
GBIHighlights

19 precision testing groups formed the International Precision Testing Industry Alliance

2023-12-31/GlobalBio & Investment
Unityisstrength!19precisiontestinggroupsformedthe"InternationalPrecisionTestingIndustryAlliance"(#LDTS Alliance)inDecember2023.RogerLiu,LDTSAlliance'sChairmanandCEOat 亞洲準譯AsiaPathogenomi...
GBI International
GBIHighlights

TAVI compiled over a century of Taiwan's vaccine history into the book

2023-12-31/GlobalBio & Investment
Knowledgeispower.TheTaiwanAssociationforVaccineIndustry(#TAVI)recentlycompiledoveracenturyofTaiwan'svaccinehistoryintothebook"AChronicleofTaiwan'sVaccineIndustry.",whichaimstopassonk...
GBI International
GBIHighlights

Win favor with Japanese investor: Insights from the 2023 Medtech Starthub

2023-12-31/GlobalBio & Investment
WanttowinfavorwithJapaneseinvestors?Focusonworkplacecultureandstrongpartnerships.Diveintotheinsightsfromthe2023MedtechStarthubeventwith #Globalbio'srecap! ReadmoretodiscoverthekeystocapturingJapan...
GBI International
GBIHighlights

Discover the groundbreaking research of Professor Jun Suzuki

2023-12-31/GlobalBio & Investment
DiscoverthegroundbreakingresearchofProfessorJunSuzuki,DeputyDirectorat iCeMS,KyotoUniversity-International.Hisdiscoveryoftheenzyme #Scramblase hassignificantimplicationsforregulatingsignalingpathwaysa...
GBI International
GBIHighlights

BUDDHIST TZU CHI GENERAL HOSPITAL teams up with Google Cloud to revolutionize healthcare

2023-12-31/GlobalBio & Investment
FromCharityto #Medtech. BUDDHISTTZUCHIGENERALHOSPITAL teamsupwith GoogleCloud torevolutionize #healthcare!Atthe2023 Healthcare+ExpoTaiwan,theyannouncedapartnershipwith EBMTechnologies tocreateasecure ...
GBI International
GBIHighlights

Sunny Pharmtech Inc.’s CPA-I successfully dispatched its inaugural shipment on 30th November

2023-12-31/GlobalBio & Investment
SunnyPharmtechInc.祥翊製藥股份有限公司’sgenericdruginjectable,Cyclophosphamide(CPA-I),successfullydispatcheditsinauguralshipmenton30thNovember,targetinga$100millionmarket.ThisFDA-approvedCPA-I,grantedinla...
GBI International
GBIHighlights

Dr. Hsing-Pang Hsieh, Director of IBPR at NHRI is elected to the National Academy of Inventors

2023-12-31/GlobalBio & Investment
Goldalwaysglitters!CongratulationstoDr. Hsing-PangHsieh,Directorof #IBPR at #NHRI,onbeingelectedtotheNationalAcademyofInventors(#NAI).✨Theirrecognitionofesteemed #innovators likeDr.Hsiehistrulyanhonor...
GBI International
GBI Highlights

MEDGAEA LIFE SCIENCES has strategically partnered with Japan's largest preclinical CRO, SNBL

2023-12-31/GlobalBio & Investment
Asthesayinggoes,ifyouwanttogofar,gotogether.Choosingtherightpartnershipiscrucialinbusinessdevelopment.MEDGAEALIFESCIENCEShasstrategicallypartneredwithJapan'slargestpreclinicalCRO, SNBL toestablish...

TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：[email protected]
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務